BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2018

Income Metrics

EPS (Diluted) €0.00

Balance Sheet Metrics

Total Assets 185.7M
Total Liabilities 141.2M
Shareholders Equity 44.5M
Debt to Equity 3.18

Cash Flow Metrics

Revenue & Profitability Trend

BNP Paribas Easy Income Statement From 2015 to 2019

Metric20192018201720162015
Revenue i26.4M38.2M80.7M109.3M121.9M
Cost of Goods Sold i33.6M34.6M61.3M69.5M81.3M
Gross Profit i-7.2M3.6M19.4M39.9M40.5M
Gross Margin % i-27.2%9.4%24.0%36.5%33.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i-10.2M-9.5M-9.0M-8.4M-7.7M
Total Operating Expenses i-10.2M-9.5M-9.0M-8.4M-7.7M
Operating Income i-41.4M-30.4M-19.7M-299.0K3.8M
Operating Margin % i-157.0%-79.5%-24.4%-0.3%3.1%
Non-Operating Items
Interest Income i-1.0K11.0K51.0K59.0K
Interest Expense i916.0K663.0K696.0K688.0K696.0K
Other Non-Operating Income-----
Pre-tax Income i-42.3M-32.7M-21.2M1.3M508.0K
Income Tax i568.0K690.0K-2.0M1.3M488.0K
Effective Tax Rate % i0.0%0.0%0.0%106.4%96.1%
Net Income i-42.9M-33.4M-19.2M-80.0K20.0K
Net Margin % i-162.5%-87.3%-23.8%-0.1%0.0%
Key Metrics
EBITDA i-24.0M-16.9M-4.7M17.4M18.7M
EPS (Basic) i-€-1.14€-0.67€0.00€0.00
EPS (Diluted) i-€-1.14€-0.67€0.00€0.00
Basic Shares Outstanding i-29152656288383162883831628838316
Diluted Shares Outstanding i-29152656288383162883831628838316

Income Statement Trend

BNP Paribas Easy Balance Sheet From 2015 to 2019

Metric20192018201720162015
Assets
Current Assets
Cash & Equivalents i3.6M4.4M3.5M12.5M16.9M
Short-term Investments i4.0K4.0K17.0K--
Accounts Receivable i1.1M879.0K7.5M8.9M12.3M
Inventory i17.3M12.3M12.3M22.1M22.7M
Other Current Assets1.0K----
Total Current Assets i34.7M30.0M35.9M54.1M62.9M
Non-Current Assets
Property, Plant & Equipment i18.0M23.9M23.4M21.6M19.1M
Goodwill i49.8M45.5M41.2M53.7M5.6M
Intangible Assets i20.0M16.3M13.2M4.1M4.5M
Long-term Investments-----
Other Non-Current Assets-2.0K----
Total Non-Current Assets i151.0M145.1M149.3M157.0M133.0M
Total Assets i185.7M175.1M185.1M211.2M195.9M
Liabilities
Current Liabilities
Accounts Payable i5.9M6.6M5.4M6.9M11.6M
Short-term Debt i60.9M18.1M8.0K307.0K895.0K
Current Portion of Long-term Debt-----
Other Current Liabilities798.0K481.0K307.0K338.0K318.0K
Total Current Liabilities i82.2M41.9M21.4M19.9M22.5M
Non-Current Liabilities
Long-term Debt i37.8M32.6M34.4M34.6M35.0M
Deferred Tax Liabilities i00000
Other Non-Current Liabilities1.7M924.0K8.1M14.9M632.0K
Total Non-Current Liabilities i59.1M45.5M45.9M52.9M37.7M
Total Liabilities i141.2M87.4M67.3M72.8M60.2M
Equity
Common Stock i145.8M145.8M144.2M144.2M144.2M
Retained Earnings i-----
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i44.5M87.7M117.8M138.4M135.7M
Key Metrics
Total Debt i98.7M50.7M34.4M34.9M35.9M
Working Capital i-47.5M-11.9M14.4M34.3M40.4M

Balance Sheet Composition

BNP Paribas Easy Cash Flow Statement From 2015 to 2019

Metric20192018201720162015
Operating Activities
Net Income i-42.9M-33.4M-19.2M-80.0K20.0K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-5.4M4.7M7.9M6.3M-6.6M
Operating Cash Flow i-47.4M-26.2M-8.1M5.5M-2.0M
Investing Activities
Capital Expenditures i-8.9M-6.0M-12.0M-15.6M-15.1M
Acquisitions i0----
Investment Purchases i-1.0K-5.0K-32.0K-101.0K-100.0K
Investment Sales i33.0K45.0K125.0K01.0K
Investing Cash Flow i-8.8M-5.5M-11.9M-23.4M-15.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i1.3M1.3M--59.0K
Free Cash Flow i-42.7M-19.0M-9.0M1.7M2.0M
Net Change in Cash i-54.9M-30.4M-20.0M-17.8M-17.1M

Cash Flow Trend

BNP Paribas Easy Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.99
Price to Sales 17.56

Profitability Ratios

Profit Margin -27.22%
Operating Margin -156.86%
Return on Equity -96.39%
Return on Assets -23.08%

Financial Health

Current Ratio 0.42
Debt to Equity 2.22

Per Share Data

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
blue463.1M15.99--96.39%-27.22%2.22
Abivax SA 5.0B-23.91-639.37-196.12%0.00%-16.16
Medincell S.A 584.8M--112.65%-66.50%-4.11
Valneva SE 857.1M70.644.50-38.02%-34.15%105.63
Inventiva S.A 536.1M-1.25-1.40172.73%0.00%-1.70
Nanobiotix 360.4M-5.10-103.70%0.00%-0.77

Financial data is updated regularly. All figures are in the company's reporting currency.